Ask AI

Optimizing Integration of Bispecific Antibody Therapy to Improve Clinical Outcomes in Patients With Multiple Myeloma

Streamline your care for patients with multiple myeloma by learning about the latest treatment strategies and expert recommendations for incorporating bispecific antibody therapy into your practice through certified on-demand webcasts, downloadable slidesets, text modules, and more!

Share

Program Content

Events

  • Live Event
    Optimizing Integration of Bispecific Antibody Therapy to Improve Clinical Outcomes in Patients With Multiple Myeloma
    Congratulations: You achieved a completion on 04/09/2022

    You can enroll in the following live event(s) on this topic.

Activities

Bispecific Antibodies in MM
Bispecific Antibody Therapy: A Guide to Navigating Your Myeloma Treatment Journey 
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: June 22, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by an educational grant from Johnson & Johnson.

Johnson & Johnson